NPX TMS Device is in the “Unsettled Times” episode of the APA Annual Meeting 2021

Santa Clara, California, May 17, 2020 – The NeuroPrex NPX TMS device was featured as one of the best technologies nationally and globally by APA-TV at the American Psychiatric Association (APA) Annual Meeting 2021 in early May. The APA-TV daily news show was streaming during the annual meeting for three days.  NeuroPrex was aired on the second episode of “The Unsettled Times”. The  APA-TV research team in London interviewed NeuroPrex CEO Janice Huang, PhD, and sent a production crew to interview the NeuroPrex team and film the product demonstration at the Santa Clara office of NeuroPrex. NeuroPrex CEO Janice Huang stated that “The NPX device is different from other TMS devices. It is our goal to deliver a more affordable and easier to use TMS device that reduces side effects and that doctors and patients are comfortable to use.”  Other medical and business advisors commented on how the NPX device works to serve the unmet need in these unsettled times for depression and PTSD treatment. For more details, please visit https://www.youtube.com/watch?v=a9yjdZHp2SM